BUPRENORPHINE

HHHRC offers buprenorphine (Suboxone®) induction at our Honolulu clinic. For questions, or to make an appointment, call the HHHRC clinic line at (808) 683-5484.

For Medical Providers 
For providers who wish to refer, please complete the Opioid Use Disorder referral form and/or call the clinic line.

For Patients
Click the button below to download our buprenorphine instruction sheet with helpful information for starting Suboxone®.

WHAT IS BUPRENORPHINE? From the Substance Abuse and Mental Health Services Administration (SAMHSA)

Buprenorphine is used to treat Opioid Use Disorder (OUD). Approved for clinical use in October 2002 by the Food and Drug Administration (FDA), medications such as buprenorphine, in combination with counseling and behavioral therapies, provide a whole-patient approach to the treatment of opioid dependency. When taken as prescribed, buprenorphine is safe and effective.

As with all medications used in MAT, buprenorphine is prescribed as part of a comprehensive treatment plan that includes counseling and participation in social support programs. Buprenorphine offers several benefits to those with opioid dependency and to others for whom treatment in a methadone clinic is not preferred or is less convenient.

Buprenorphine has unique pharmacological properties that help:

  • Lower the potential for misuse

  • Diminish the effects of physical dependency to opioids, such as withdrawal symptoms and cravings

  • Increase safety in cases of overdose

 

Buprenorphine is an opioid partial agonist. This means that, like opioids, it produces effects such as euphoria or respiratory depression at low to moderate doses. With buprenorphine, however, these effects are weaker than full opioid agonists such as heroin and methadone. Buprenorphine’s opioid effects increase with each dose until at moderate doses they level off, even with further dose increases. This “ceiling effect” lowers the risk of misuse, dependency, and side effects. Also, because of buprenorphine’s long-acting agent, many patients may not have to take it every day.

RESOURCES

Information about Buprenorphine from the Substance Abuse and Mental Health Services Administration (SAMHSA)

Medication to Treat Addiction Involving Opioid Use 2018 Fact Sheet from the American Society of Addiction Medicine (ASAM)

The National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use from ASAM

HHHRC HIGHLIGHTS

WAD raymond.jpg

December 2, 2019

HHHRC's Raymond Alejo Receives Suzanne Richmond-Crum Award on World AIDS Day

Raymond, registered nurse case manager at HHHRC, was recognized for his 19 years of work in Hawaiʻi advocating for and serving people living with HIV. Every year, the Suzanne Richmond-Crum Award is given to a community member who has made outstanding contributions in the provision of HIV/AIDS services. Read the DOH press release here, and visit worldaidsdayhawaii.org to learn more. Congratulations to Raymond for this well-deserved award!

HHHRC MEDIA

RENT collaborated with HHHRC for a special World AIDS Day performance!

  • White Facebook Icon
  • social-instagram-white
  • White Twitter Icon
  • White YouTube Icon
  • email-stretch-white

Office Hours: M-F 8:30AM–12:30PM, 1:00PM–5:00PM

Testing Hours: M-F 9:00AM12:30PM, 1:00PM4:00PM

Address: 677 Ala Moana Blvd. Suite 226  Honolulu, HI  96813

Email: info@hhhrc.org     Tel:  (808) 521-2437

Copyright 2019 Hawai'i Health & Harm Reduction Center